Literatur
-
1
Rongioletti F.
Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema.
J Am Acad Dermatol.
2001;
44
273-281
-
2
Harper R A, Rispler J.
Lichen myxoedematosus serum stimulates human skin fibroblast proliferation.
Science.
1978;
199
545-547
-
3 Meigel W N, Stemm A. Ablagerungsdermatosen.. In: Kerl H, Garbe C, Cerroni L, Wolff H H, Hrsg. Histopathologie der Haut.. Berlin, Heidelberg: Springer; 2003: 487-491
-
4 Weedon D. Skin pathology.. 2nd ed. London, New York: Churchill Livingstone; 2002: 406-408
-
5
Körber A, Franckson T, Grabbe S et al.
Successful therapy of scleromyxoedema Arndt-Gottron with low-dose intravenous immunglobulin.
J Eur Acad Dermatol Venereol.
2007;
21
553-554
-
6
Mihaljevic N, von den Driesch P.
Intravenöse Low-Dose-Immunglobulintherapie beim Skleromyxödem.
Akt Dermatol .
2010;
36
313-315
-
7
Majeski C, Taher M, Grewal P et al.
Combination oral prednisone and intravenous immunoglobulin in the treatment of scleromyxedema.
J Cutan Med Surg.
2005;
9
99-104
-
8
Sroa N, Campbell S, Bechtel M.
Intravenous immunoglobulin therapy for scleromyxedema: a case report and review of literature.
J Drugs Dermatol.
2010;
9
263-265
Olga Sperling
Zentrum für Hautkrankheiten
Prießnitzweg 24
70374 Stuttgart
eMail: o.sperling@Klinikum-stuttgart.de
